These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 22230040

  • 1. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, Daiber A, Nickenig G, Wassmann S.
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [Abstract] [Full Text] [Related]

  • 2. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 3. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug 13; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S, Czech T, van Eickels M, Fleming I, Böhm M, Nickenig G.
    Circulation; 2004 Nov 09; 110(19):3062-7. PubMed ID: 15277329
    [Abstract] [Full Text] [Related]

  • 5. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, Iwai M, Horiuchi M, Sunagawa K.
    Hypertens Res; 2008 Sep 09; 31(9):1791-800. PubMed ID: 18971558
    [Abstract] [Full Text] [Related]

  • 6. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D, Enomoto S, Hirata Y, Nagai R, Sata M.
    Biomed Pharmacother; 2010 Dec 09; 64(10):712-7. PubMed ID: 20970951
    [Abstract] [Full Text] [Related]

  • 7. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
    Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA.
    Circulation; 2004 Dec 21; 110(25):3849-57. PubMed ID: 15596561
    [Abstract] [Full Text] [Related]

  • 8. Transplantation of periaortic adipose tissue from angiotensin receptor blocker-treated mice markedly ameliorates atherosclerosis development in apoE-/- mice.
    Irie D, Kawahito H, Wakana N, Kato T, Kishida S, Kikai M, Ogata T, Ikeda K, Ueyama T, Matoba S, Yamada H.
    J Renin Angiotensin Aldosterone Syst; 2015 Mar 21; 16(1):67-78. PubMed ID: 25324424
    [Abstract] [Full Text] [Related]

  • 9. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
    Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C.
    Circ Res; 2010 Oct 01; 107(7):888-97. PubMed ID: 20671240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.
    Bernardi S, Candido R, Toffoli B, Carretta R, Fabris B.
    Nephrol Dial Transplant; 2011 Mar 25; 26(3):832-8. PubMed ID: 20810455
    [Abstract] [Full Text] [Related]

  • 16. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.
    Vinh A, Widdop RE, Drummond GR, Gaspari TA.
    Cardiovasc Res; 2008 Jan 25; 77(1):178-87. PubMed ID: 18006471
    [Abstract] [Full Text] [Related]

  • 17. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
    Hoyer FF, Steinmetz M, Zimmer S, Becker A, Lütjohann D, Buchalla R, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2011 Dec 25; 51(6):1007-14. PubMed ID: 21884703
    [Abstract] [Full Text] [Related]

  • 18. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 25; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
    Takaya T, Kawashima S, Shinohara M, Yamashita T, Toh R, Sasaki N, Inoue N, Hirata K, Yokoyama M.
    Atherosclerosis; 2006 Jun 25; 186(2):402-10. PubMed ID: 16157344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.